Post-IPO Debt - Appili Therapeutics
Investment Firm
Overview
Appili Therapeutics is an anti-infective pharmaceutical development company.
Announced Date
Mar 20, 2023
Funding Type
Post Ipo Debt
Highlights
Location
North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Appili Therapeutics raised $1828448 on 2023-03-20 in Post-IPO Debt
Appili Therapeutics is an anti-infective pharmaceutical development company.
Company Funding History
17
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 23, 2017 |  Seed Round - Appili Therapeutics | 1 | - | 3.1M |
| Feb 17, 2017 | Grant - Appili Therapeutics | 1 | - | 2.8M |
| Dec 21, 2016 | Seed Round - Appili Therapeutics | 1 | - | 1.6M |
| May 25, 2016 | Seed Round - Appili Therapeutics | 3 | - | 3.3M |
Recent Activity
There is no recent news or activity for this profile.